The ATS partners with individuals, industry, and non-profit organizations, pooling resources to maximize the number of high-impact projects that can be funded. A guiding principle of the ATS Research Program is to collaborate with other medical, research, clinical, professional, corporate, patient, and non-profit organizations that are focused on the diagnosis, understanding, and treatment of lung disease.
Special thanks to our partners funding a research grant starting in 2023!
Our research partners sharing research priorities and funding responsibilities are:
4DMedical
Alpha-1 Foundation
Alveolar Capillary Dysplasia Association
American Lung Association
American Thoracic Society Public Advisory Roundtable
ARDS Foundation
Asthma and Allergy Foundation of America*
Boehringer-Ingelheim Pharmaceuticals, Inc.
CHEST Foundation
Children’s Interstitial Lung Disease Foundation
COPD Foundation*
CSL Behring
Cystic Fibrosis Foundation
Fisher & Paykel Healthcare
Foundation for Sarcoidosis Research*
Hermansky-Pudlak Syndrome Network*
Mallinckrodt Pharmaceuticals, Inc.
Primary Ciliary Dyskinesia (PCD) Foundation*
Pulmonary Hypertension Association
Sepsis Alliance
Veterans Administration
Interested in becoming a Research Program Partner?
Email researchprogram@thoracic.org for more information.
* Current members of the ATS Public Advisory Roundtable (PAR)
More information about ATS PAR.